No Data
Express News | Henlius: On Morning of Nov 7, Entered Into a Strategic Collaboration With Al-Tiryaq Al-Khalawi Medical Company
Henlius and SVAX Forge Strategic Partnership in the MENAT Market
Henlius to Establish Saudi Arabia JVs to Distribute Drugs to Middle East
Henlius, XtalPi Sign Deals to Expand Abroad as Chinese Drug Companies 'Go Out' for Growth
US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar Candidate of PROLIA/XGEVA (Denosumab)
Henlius (02696): The biological product license application (BLA) for HLX14, a biosimilar of Denosumab (recombinant anti-RANKL monoclonal antibody injection), has been accepted by the Food and Drug Administration (FDA) of the United States.
Henlius (02696) announced that recently, the company independently developed PROLIA/XGEVA(...
No Data
No Data
